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within a 3D biomimetic skeletal muscle culture platform. 
Here, we review the current state of the art for engineering 
neuromuscular contacts in vitro  and provide original data 
detailing the development of a 3D collagen-based model for 
the co-culture of primary muscle cells and motor neurons. 
The devised culture system promotes increased myoblast 
differentiation, forming arrays of parallel, aligned myotubes 
on which areas of nerve-muscle contact can be detected by 
immunostaining for pre- and post-synaptic proteins. Quan-
titative RT-PCR results indicate that motor neuron presence 
has a positive effect on myotube maturation, suggesting 
neural incorporation influences muscle development and 
maturation in vitro. The importance of this work is discussed 
in relation to other published neuromuscular co-culture 
platforms along with possible future directions for the field. 
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 Abstract 
 Effective models of mammalian tissues must allow and en-
courage physiologically (mimetic) correct interactions be-
tween co-cultured cell types in order to produce culture mi-
croenvironments as similar as possible to those that would 
normally occur in vivo. In the case of skeletal muscle, the 
development of such a culture model, integrating multiple 
relevant cell types within a biomimetic scaffold, would be of 
significant benefit for investigations into the development, 
functional performance, and pathophysiology of skeletal 
muscle tissue. Although some work has been published re-
garding the behaviour of in vitro muscle models co-cultured 
with organotypic slices of CNS tissue or with stem cell-de-
rived neurospheres, little investigation has so far been made 
regarding the potential to maintain isolated motor neurons 
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 Introduction
Engineering in vitro Neuromuscular Junctions 
 In seeking to engineer in vitro culture models that ac-
curately recapitulate the physiology and function of in 
vivo tissues, there is a critical need to develop platforms 
in which the principal cell types can interact correctly. 
Therefore, in order to model skeletal muscle effectively, 
the engineered tissue should be able to generate biologi-
cally accurate representations of the vascular interface as 
well as the myotendinous and neuromuscular junctions 
(NMJs). The successful development of 3D skeletal mus-
cle models which enable interaction with these support-
ing tissues and structures would lead to the development 
of mature and biologically accurate model systems for 
musculoskeletal disease modelling, drug screening, and 
developmental or mechanistic studies [Larkin et al., 
2006b]. Previous publications have focused on the devel-
opment of both vascular [Levenberg et al., 2005; Borschel 
et al., 2006; Hadjipanayi et al., 2011; Juhas et al., 2014] and 
myotendinous interfaces [Larkin et al., 2006a; Kostromi-
nova et al., 2009] within existing in vitro skeletal muscle 
models. However, the development of robust, fully func-
tional NMJs in vitro has yet to be demonstrated. 
 Motor Neuron-Myotube Co-Cultures 
 Although co-culture of nerve and muscle tissue was 
first attempted over a century ago [Harrison et al., 1907], 
it is only relatively recently that significant methodologi-
cal advances have been made. Conventional cell culture 
techniques have shown that motor neurons are capable of 
eliciting end-plate potentials in co-cultured myotubes. 
Dual-patch analysis of mouse embryonic stem cell (ESC)-
derived motor neurons and C2C12 myotubes co-cultured 
at low density has shown that electrical activation of neu-
rons will trigger post-synaptic potentials in associated 
muscle fibres in vitro [Umbach et al., 2012]. Similarly, 
functional analysis of primary rat skeletal muscle myo-
tubes on microscale cantilevers has demonstrated that ac-
tivation of co-cultured primary rat embryonic ventral 
horn motor neurons through application of glutamate 
will induce contractile activity in underlying myotubes. 
Such activation has also been shown to be subsequently 
blocked through addition of the acetylcholine receptor 
(AChR) inhibitor  D -tubocurarine [Smith et al., 2013]. 
Co-cultures of human cells have even provided evidence 
for functional contact between these cell types, again 
though blockage of contractile activity through treatment 
with  D -tubocurarine [Guo et al., 2011]. In addition, mod-
ified Campenot chambers have been developed to sepa-
rate neuron and muscle cell bodies in order to better 
model the compartmentalised nature of the in vivo  pe-
ripheral nervous system [Southam et al., 2013]. Microflu-
idic chambers have also been developed, in which fluids 
are manipulated at the submillimetre scale [Taylor et al., 
2006]. Using this approach, multicompartment culture 
chambers can be produced which not only enable neuro-
nal processes and muscle cells to be fluidically isolated 
from cell bodies, but also allows the cells to be monitored 
by live cell imaging, as well as phase, differential interfer-
ence contrast, and fluorescence microscopy [Taylor et al., 
2006]. 
 These systems provide valuable proof of concept for 
the generation of functional synapses between motor 
neurons and muscle cell types in vitro, and similar sys-
tems have been used to investigate acetylcholinesterase 
production and cycling at the NMJ [Jevsek et al., 2004; 
Mis et al., 2005], highlighting how such models can be 
used for mechanistic evaluation of neuromuscular synap-
tic function. However, immunocytochemical data from 
these studies indicate a relatively immature state of devel-
opment in these in vitro  NMJs. Cultured synapses typi-
cally lack an invaginated, ‘pretzel-like’ structure in the 
post-synaptic membrane, have low AChR cluster density, 
display a paucity of specialised subsynaptic nuclei, and 
 
Abbreviations used in this paper
AChR acetylcholine receptor
AChRε acetylcholine receptor ε-subunit
ALS amyotrophic lateral sclerosis
BSA bovine serum albumin
DIV days in vitro
DMEM Dulbecco’s modified Eagle’s medium
ESC embryonic stem cell
HBSS Hanks’ balanced saline solution
iPSC induced pluripotent stem cell
MAP-2 microtubule-associated protein-2
MDC muscle-derived cell
MYH1 myosin heavy chain 1 (adult fast isoform)
MYH3 myosin heavy chain 3 (embryonic isoform)
MYH8 myosin heavy chain 8 (neonatal isoform)
NGS normal goat serum
NMJ neuromuscular junction
P1 postnatal day 1
P/S penicillin/streptomycin
PBS phosphate-buffered saline
RPIIB RNA polymerase II β-subunit
RT-PCR reverse transcription polymerase chain reaction
SV-2 synaptic vesicle protein-2
TBS Tris-buffered saline
TGF-β transforming growth factor-β
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rarely promote pre-synaptic terminal development and 
specialisation. These structural and molecular motifs are 
well-established hallmarks of mature NMJs [Sanes and 
Lichtman, 1999, 2001] and are necessary for accurate 
modelling of these synapses for drug screening, disease 
modelling, and fundamental mechanistic studies. Re-
cently, the development of more structurally mature 
NMJs in conventional co-culture has been reported 
[Chipman et al., 2014]. Mouse ESC-derived motor neu-
rons encased in embryoid bodies and co-cultured with 
embryonic chick myotubes were shown to develop ad-
vanced end-plate morphologies reminiscent of NMJs in 
vivo ,  demonstrating that the achievement of such struc-
tures is possible in vitro . Furthermore, this model was 
used to characterise synaptic development in neural cell 
adhesion molecule (NCAM)–/– mutant cells, providing 
valuable data regarding the role of NCAM in modulating 
synaptic vesicle endocytosis to influence neuromuscular 
synaptogenesis. Results such as these highlight the poten-
tial utility of advanced NMJ models for conducting mech-
anistic evaluation of synaptic development, and even for 
drug screening or disease modelling applications. 
 3D Muscle Constructs for Motor Neuron-Myotube 
Co-Culture Studies 
 Culturing of skeletal muscle cells in a 3D environment 
through integration with an exogenous matrix material 
has been shown to significantly improve the maturation 
state of cultured myotubes, with respect to levels of mus-
cle cell fusion, contractile force output, sarcomeric devel-
opment, cellular organisation, and up-regulation of mus-
cle-specific myogenic regulatory factors [Vandenburgh 
et al., 1999; Dennis et al., 2001; Powell et al., 2002; Mudera 
et al., 2010; Hinds et al., 2011; Smith et al., 2012; Juhas et 
al., 2014; Madden et al., 2015]. Given the immature na-
ture of many in vitro  NMJ culture systems, it seems plau-
sible that improvements in cellular maturation may pro-
mote the development of more robust and developmen-
tally advanced synapses in such culture models.
 Co-culture of 3D, fibrin-based, skeletal muscle con-
structs with organotypic neuronal slices has previously 
been shown to promote the up-regulation of important 
NMJ markers such as the AChR ε-subunit (AChRε) and 
the dihydropyridine receptor Trisk 51 [Bach et al., 2003]. 
Likewise, myosin heavy chain expression patterns appear 
to progress from neonatal isoforms towards a more de-
velopmentally mature phenotype in such constructs [Lar-
kin et al., 2006b]. Myotubes co-cultured with neuronal 
tissue in 3D exhibit spontaneous contractions that can be 
blocked by treatment with depolarising and non-depola-
rising muscle relaxants, as well as significant increases in 
peak twitch and tetanic contractile responses to timed 
electrical stimuli. Similarly, fibrin-based constructs seed-
ed with muscle-derived cells (MDCs) and implanted in 
close proximity to the transected femoral nerve of adult 
rats have demonstrated far greater contractile function 
when compared with control cultures following 4 weeks 
in situ [Dhawan et al., 2007]. Recently, work has been 
published demonstrating the production of a co-culture 
system supporting synaptic contact between aligned 
myotubes and motor neuron neurospheres derived from 
mouse neural stem cells [Morimoto et al., 2013]. These 
cultures were also able to promote improved contractile 
properties compared with muscle-only controls and 
spontaneous twitch activity that was interrupted by treat-
ment with the AChR blocker curare.
 Limitations of Current Models 
 Such studies demonstrate the improvement in MDC 
maturation that can be brought about by the inclusion of 
neuronal tissue within a 3D skeletal muscle model and 
highlight the corresponding improvement in contractile 
function that this generates. However, the work to date 
has still failed to promote the development of structur-
ally and functionally mature NMJs as would be seen in 
vivo .  Moreover, the majority of work to date focuses on 
the use of either organotypic slices of central nervous sys-
tem tissue [Bach et al., 2003; Larkin et al., 2006b], tran-
sected nerve tissue [Dhawan et al., 2007], or aggregated 
and ill-defined neurospheres [Morimoto et al., 2013] to 
provide the neural input for the seeded muscle cells. Con-
sequently, there remains some ambiguity as to whether or 
not isolated motor neurons are capable of surviving and 
interacting correctly with MDCs within a 3D culture en-
vironment, and whether the other cell types found in neu-
rosphere models can indeed enhance/interact with neu-
rons to support maturation. 
 The development of induced pluripotent stem cell 
(iPSC)-derived motor neurons capable of accurately 
modelling peripheral neuropathies [Dimos et al., 2008; 
Bilican et al., 2012; Chestkov et al., 2014; Demestre et al., 
2015] suggests that the development of 3D biomimetic 
culture platforms for the study of diseases such as amyo-
trophic lateral sclerosis (ALS) may be possible in the near 
future [Richard and Maragakis, 2014]. However, the es-
tablishment of such model systems is predicated on the 
development of culture protocols for maintaining disso-
ciated single neurons with engineered skeletal muscle tis-
sue in the medium to long term. Furthermore, the pub-
lished work on this subject has so far been limited to
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investigation of fibrin- and Matrigel-based constructs 
[Bach et al., 2003; Larkin et al., 2006b; Dhawan et al., 2007; 
Morimoto et al., 2013]. At present, there are no published 
data regarding the ability to promote neuromuscular 
 interaction within alternative in vitro matrices. Critical 
appraisal of the suitability of a given 3D system for study-
ing neuromuscular interaction in vitro necessitates the 
dissemination of data obtained from a variety of suitable 
matrices in order to discern which scaffold possesses the 
most appropriate characteristics for continued investiga-
tion. Given the high concentration of collagen in the ex-
tracellular matrix of native skeletal muscle [Gillies et al., 
2014], it is sensible to assume that collagen matrices 
would represent a suitable in vitro  scaffold for use in en-
gineering more biomimetic skeletal muscle tissues. Eval-
uation of the capacity of collagen matrices to promote 
synaptic development in motor neuron-myotube co-cul-
tures is therefore worthy of investigation and subsequent 
comparison to similar data obtained in published fibrin 
and Matrigel systems.
 Analysis of Isolated Motor Neuron Interaction with 
a Tissue-Engineered Biomimetic 3D Skeletal Muscle 
Model  
 As part of this study, we present the development of a 
3D, collagen-based, co-culture system for the mainte-
nance of aligned, primary MDCs and ventral horn motor 
neurons. This work is based on the development of a well-
established long-term culture model for maintaining pri-
mary skeletal muscle myotubes in 3D constructs [Smith 
et al., 2012]. The stability of this culture system in turn 
makes it a strong candidate for enabling the generation of 
long-term 3D nerve-muscle co-cultures in order to anal-
yse synaptic development in vitro .  Additionally, the de-
veloped model is amenable to mechanical loading tech-
niques [Player et al., 2014], which will enable subsequent 
studies into the role of mechanical cues in driving neuro-
muscular development. 
 The ability for synaptic contacts to form within this 
model and the positive effect of the neuronal presence on 
the MDC phenotype were confirmed and quantified. The 
presented data validate the potential for isolated single 
neurons to survive and influence myotube development 
in 3D co-culture, paving the way for the integration of 
isolated stem cell-derived motor neurons with biomimet-
ic skeletal muscle cultures. Such culture systems will be 
invaluable for furthering our understanding of disease 
pathogenesis as well as for providing a reliable pre-clini-
cal test bed for the future development of novel therapeu-
tics. 
 Materials and Methods 
 Cell Culture 
 Establishment of Primary MDC Cultures 
 On postnatal day 1 (P1) Sprague-Dawley rat pups were eu-
thanised by cervical dislocation, in accordance with the code of 
practice for the humane killing of animals under Schedule 1 of the 
Animals (Scientific Procedures) Act 1986. The protocol for the iso-
lation of MDCs, as well as the verification of a stable myogenic pop-
ulation present among the isolated cells, has been previously de-
scribed in detail [Smith et al., 2012]. Briefly, following removal of 
the skin, the hindlimbs were transferred to a Petri dish containing 
phosphate-buffered saline (PBS) solution (Sigma-Aldrich, Poole, 
UK) supplemented with 2% penicillin (100 units/ml)/streptomycin 
(100 μg/ml) (P/S) (Gibco/Invitrogen, Paisley, UK). The muscle tis-
sue was separated from the bone before both bone and cartilage 
were removed from the Petri dish and discarded. The muscle tissue 
fragments were then suspended in 0.1% collagenase (Gibco/Invi-
trogen) in PBS and incubated in a 37  °  C shaking incubator set to 300 
rpm for 50 min, or until the tissue was fully digested. 
 The resulting cell solution was passed through a 100- and then 
a 40-μm mesh filter (BD Biosciences) in order to remove any debris 
or undigested tissue fragments, before being spun at 450  g for 10 
min. The cells were then re-suspended in 500 μl standard growth 
medium (medium 1 ; see online suppl. table 1; for all online suppl. 
material, see www.karger.com/doi/10.1159/000443634) consist-
ing of high-glucose Dulbecco’s modified Eagle’s medium (DMEM) 
(Gibco/Invitrogen) supplemented with 20% fetal calf serum (PAA, 
Yeovil, UK) and 1% P/S. 
 Isolated MDCs for 2D experiments were seeded onto gelatin-
coated, 13-mm, sterile, glass coverslips at a density of 50,000 cells/
cm 2 . Cultures were maintained in medium 1 until they reached 
confluency. At this point, the medium was replaced with a differ-
entiation medium (medium 2; see online suppl. table 1) in order to 
promote fusion of the myogenic cells. Agrin and Wnt3 were added 
to the medium since they have been found to significantly improve 
levels of post-synaptic differentiation in cultured myotubes [Hen-
riquez and Salinas, 2012]. The ability for these proteins to improve 
the number of AChR clusters formed on cultured myotubes when 
included in the feeding medium, as reported previously, was veri-
fied during initial optimisation of culture parameters (online suppl. 
fig. 1). Cultures were maintained in medium 2 for 3 days (for myo-
blast purity assessment) or 10 days (for myotube fusion assess-
ment) before being fixed and prepared for post-hoc analysis.
 Establishment of Primary Mixed Ventral Horn Cultures 
 Primary motor neurons were isolated from rat embryos at ges-
tational age E14 using a method modified from that described by 
Henderson et al. [1995] and Kalmar and Greensmith [2009]. Preg-
nant Sprague-Dawley females were euthanised by exposure to a 
rising concentration of carbon dioxide gas, in accordance with the 
code of practice for the humane killing of animals under Schedule 
1 of the Animals (Scientific Procedures) Act 1986.
 Embryos were removed following hysterectomy and transferred 
to a Petri dish containing Hanks’ balanced saline solution (HBSS) 
(Sigma-Aldrich) supplemented with 2% P/S. Spinal cords were sep-
arated from the surrounding tissue and the meninges carefully re-
moved. The dorsal horn was then cut away from the ventral portion 
of the spinal cord and discarded. The ventral horns from individual 
embryos were pooled and incubated in a 0.025% trypsin solution 
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(type XII-S) (Sigma-Aldrich) in HBSS for 10 min. They were then 
transferred to a fresh solution containing 800 μl L-15 medium (Gib-
co/Invitrogen), 100 μl 4% bovine serum albumin (BSA) (Sigma-Al-
drich) and 100 μl DNase (1 mg/ml stock) (Sigma-Aldrich). The spi-
nal cords were agitated vigorously until they had disaggregated and 
were then triturated using a P1000 tip and left to settle. After 2 min, 
the solution was transferred to a 15-ml centrifuge tube (care was 
taken to avoid transferring any undissociated fragments). This pro-
cess was repeated twice and the three supernatants were pooled be-
fore being spun through a 1-ml 4% BSA cushion for 5 min at 370  g .
 Once the supernatant had been removed, the pellet was re-sus-
pended in medium 2 and plated onto polyornithine- and laminin-
treated, 13-mm, sterile glass coverslips at a density of 25,000 cells/
cm 2 . Cultures were maintained in vitro for 7 days before being 
prepared for analysis. During this culture period, the feeding me-
dium was changed every 2–3 days.
 Establishment and Maintenance of 3D Primary MDC 
Cultures 
 The protocol for establishing 3D cultures of aligned myotubes 
has been previously described in detail [Smith et al., 2012] and was 
adapted from methods developed for use with the culture force 
monitor system [Brady et al., 2008; Mudera et al., 2010]. Type 1 rat 
tail collagen (2.6 ml at 2.05 mg/ml in 0.1  M acetic acid; First Link, 
Wolverhampton, UK) was mixed with 300 μl 10× minimal essential 
medium (Gibco/Invitrogen). 5  M NaOH (VWR) was then added 
dropwise until a colour change from yellow to pink was observed. 
This solution was then supplemented with 300 μl of medium 1 con-
taining 15 × 10 6 primary rat MDCs. The cell-collagen solution was 
pipetted into a prepared single-well chamber slide (Nunc, New 
York, N.Y., USA) containing a collagen-coated flotation bar fixed 
at either end ( fig. 1 a). The construct was incubated for 30 min or 
until the collagen gel had set. After incubation, the construct was 
cut away from the sides of the chamber slide using a sterile needle 
and floated in medium 1. Care was taken to ensure the construct 
was fully detached from all surfaces except the flotation bars. After 
4 days in vitro  (DIV), medium 1 was replaced with medium 2 for 
the remainder of the culture period. All media were replaced daily.
 Establishment and Maintenance of 3D Primary MDC-Motor 
Neuron Co-Cultures 
 3D muscle constructs were established as described above  and 
maintained in medium 1 for 4 days. At this point, medium 1 was 
replaced with medium 2 and 1 × 10 6 mixed ventral horn cells, sus-
pended in 100 μl medium 2, were pipetted directly onto the upper 
surface of the collagen gel. Constructs were returned to the incuba-
tor and maintained for a further 14 days before being prepared for 
analysis. Media were changed daily throughout the culture period.
 Immunocytochemistry 
 Cultures were fixed with an ice-cold methanol/acetone solu-
tion. 3D constructs (and in vivo tissue sample controls from P1 rat 
hindlimbs) were then dehydrated in a sucrose solution, frozen in 
OCT medium (Tissue-Tek/Sakura Finetek Europe, Alphen aan 
den Rijn, The Netherlands) and sectioned using a Bright TM cryo-
stat; 30-μm sections were collected on poly- L -lysine-coated slides 
(VWR) and air-dried for 1 h before staining. 3D and 2D samples 
were permeabilised using 1× Tris (0.5  M ) buffered saline solution 
(TBS) [+ 5% normal goat serum (NGS) and 0.2% Triton X-100] for 
1 h. They were then incubated overnight at 4   °   C with the chosen 
primary antibody diluted in TBS (+ 2% NGS and 0.2% Triton 
X-100). After overnight incubation, the samples were washed 
thoroughly in TBS before being treated with a secondary antibody, 
again diluted in TBS (+ 2% NGS and 0.2% Triton X-100). Nuclei 
were identified using the fluorescent minor-groove DNA-binding 
probe DAPI (4,6-diamidino-2-phenylindole; 1.0 ng/ml; Sigma-Al-
drich), which was incorporated into the secondary antibody incu-
bation stage. The samples were incubated for 3 h at room temper-
ature in a darkened chamber before being dried and mounted with 
glass coverslips (VWR) using a drop of Mowiol mounting medi-
um. 2D controls were dried and affixed to glass microscope slides, 
again using a drop of Mowiol mounting medium. Cells were visu-
alised using a Zeiss LSM510 Meta confocal microscope.
 Immunocytochemical analysis of 2D and 3D cultures was carried 
out using antibodies to a number of markers of muscle and motor 
axons, including antibodies to desmin (Dako, Ely, UK;  1: 200), mi-
crotubule-associated protein-2 (MAP-2; Millipore, Watford, UK; 1:  
 1,000), neurofilament (DSHB, Iowa City, Iowa, USA; 1: 10), and syn-
aptic vesicle protein-2 (SV-2; DSHB; 1: 10), and markers of myo-
tubes, neurons, axons, and pre-synaptic terminals, respectively. Tex-
as-red-conjugated α-bungarotoxin (Sigma-Aldrich; 1: 1,000) was 
also used to label AChR clusters on the post-synaptic myotube mem-
brane. The secondary antibodies used were Alexa Fluor 488 donkey 
anti-mouse IgG (Gibco/Invitrogen) and Alexa Fuor 594 donkey an-
ti-rabbit IgG (Gibco/Invitrogen), both diluted 1: 200.
 Image Analysis 
 MDCs and mixed ventral horn cells were stained for desmin 
and MAP-2, respectively. Nuclei were visualised by staining with 
the DNA-binding probe DAPI, and the number of nuclei present 
was used to calculate the percentage positivity of myoblasts and 
motor neurons in their respective cultures. 
 A myoblast was identified as any mononuclear desmin-positive 
cell, while a myotube was defined as a desmin-positive cell with at 
least 3 nuclei. Motor neurons were defined as MAP-2-positive cells 
with a cell body greater than 15 μm in diameter with at least 3 neu-
ritic processes. 
 Cultures stained using Texas-red-conjugated α-bungarotoxin 
were analysed for clusters of AChR. An AChR cluster was classified 
as foci of red staining separate and distinct from others nearby and 
clearly distinguishable above background staining levels. Macro-
scopic images of 3D constructs were taken using a Canon Power-
Shot A460 5.0 MP digital camera and analysed using ImageJ soft-
ware (National Institutes of Health, USA).
 Quantitative One Step Reverse-Transcription Polymerase 
Chain Reaction 
 3D constructs were homogenised using an IKA Ultra-Turrax 
T10 homogeniser (Fisher Scientific, UK) in TRIzol reagent (Sig-
ma-Aldrich). RNA was extracted according to the manufacturer’s 
instructions and re-suspended in RNA storage solution (Ambion, 
Life Technologies, Paisley, UK). RNA quantity was determined 
spectrophotometrically using a Nanodrop 2000c. 
 Quantitative one step reverse-transcription polymerase chain re-
action (RT-PCR) was performed using a Qiagen Rotor-Gene Q and 
SYBR green RT-PCR (Qiagen, Crawley, UK) one-step chemistry kit; 
70 ng of total RNA were added per PCR, and reactions were per-
formed in triplicate. The thermal cycling protocol consisted of a 10-
min reverse transcription step at 50  °  C, followed by 40 cycles of 10 s 
at 95  °  C (denaturation) and 30 s at 60  °  C (annealing and extension). 
D
ow
nl
oa
de
d 
by
: 
15
8.
12
5.
80
.2
20
 - 
2/
8/
20
17
 1
1:
58
:5
6 
AM
 Smith/Passey/Martin/Player/Mudera/
Greensmith/Lewis
 
 Cells Tissues Organs 2015–16;202:143–158 
DOI: 10.1159/000443634
148
RT-PCR data were analysed by relative quantification, using the 
2–ΔΔC T method [Livak and Schmittgen, 2001]. Gene expression in 
both MDC-only and co-culture samples were normalised to RNA 
polymerase II β-subunit (RPIIB) and expressed relative to MDC-
only constructs. Primers sequences used are provided in online sup-
plementary table 2. 
 Following RT-PCR, the products of these reactions were sepa-
rated using horizontal agarose gel electrophoresis. PCR products 
were excised and purified using the QIAquick gel extraction kit 
according to the manufacturer’s protocol (Qiagen). They were 
then sent for sequencing at Geneservice (London, UK). Sequences 
were analysed using FinchTV software and compared to the 
known DNA sequence from an online database of the respective 
gene (www.ncbi.nlm.nih.gov) in order to confirm the validity of 
the primers used for amplifying sequences from the target gene.
 Statistical Analysis 
 All experiments were repeated at least 3 times using cultures 
prepared on different days from pups of different litters. For all 
relevant experiments, statistical significance between 2 groups 
(e.g. 3D cultures ± motor neurons) was assessed using t tests in 
SigmaStat (version 2.03; Systat Software, Erkrath, Germany). For 
quantitative RT-PCR analysis, mRNA levels in co-culture were ex-
pressed relative to MDC-only control values. Since all MDC-only 
values were therefore equal to 1, a one-sample t test was used to 
evaluate whether relative gene expression levels in co-culture were 
significantly different from 1. All values detailed in this paper are 
expressed as means ± SEM. Significance was set at p < 0.05.
 Results 
 MDC Differentiation Using Defined Media 
 Since MDCs and motor neurons exhibit distinct nutri-
ent requirements in order to sustain growth and promote 
differentiation in vitro, medium 2 was developed specifi-
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 Fig. 1. 3D co-culture platform and cell pop-
ulation characterization.  a A chamber slide 
(1) fitted with custom-built flotation bars 
at either end (2). A cell-laden collagen solu-
tion is allowed to gel between the flotation 
bars. The collagen gel is then detached 
from the edges of the chamber slide so that 
it floats in the culture medium. Cell-medi-
ated matrix compaction leads to the gen-
eration of isometric strain between the 
 flotation bars (white arrow). Compaction 
of the collagen gel over time produces the 
characteristic bowing illustrated (3). Scale 
bar = 10 mm.  b Image of MDCs main-
tained in this culture platform for 2 weeks 
and stained for desmin (green) and nuclei 
(blue). Note the parallel alignment of the 
developing myotubes. Scale bar = 20 μm.
 c Image of a muscle tissue section taken 
from a P1 rat pup, cryosectioned, and 
stained for desmin (green) and nuclei 
(blue). Scale bar = 20 μm.  d Image of 
ventral horn motor neurons maintained 
on glass coverslips for 7 days before being 
stained for MAP-2 (red) and nuclei (blue). 
Scale bar = 40 μm.  e Comparison of fusion 
efficiency in MDC-only 3D constructs ver-
sus motor neuron-muscle co-cultures. p = 
0.86. 
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cally for the maintenance of these cell types in a 3D co-
culture system. It was adapted from a medium used to 
maintain motor neurons in vitro and contains all the nec-
essary factors to facilitate MDC differentiation. To verify 
the ability of this medium to promote myoblast differen-
tiation, confluent MDCs were maintained in medium 2 
for 3 days. The cultured cells were then fixed, stained for 
desmin, and assessed for fusion efficiency [the number of 
myogenic nuclei incorporated into myotubes (calculated 
as a percentage of the total number of myogenic nuclei 
present in culture)].
 MDCs cultured in medium 2 on glass coverslips exhib-
ited a fusion efficiency of 71.22% (±2.76), indicating that 
almost 3 quarters of all myogenic cells in culture were able 
to form myotubes when maintained in this medium. Our 
previous work with MDC-only cultures found that con-
ventional differentiation medium, consisting of low-per-
centage horse serum in high-glucose DMEM, promoted 
fusion efficiencies of 61.46% (±1.16) [Smith et al., 2012]. 
The results obtained for cultures maintained in medium 
2 were significantly greater than those obtained when the 
cells were exposed to a more conventional muscle differ-
entiation medium, as detailed in our previous publication 
(p < 0.05). This observation indicates that the presence of 
the neuronal growth factors used in medium 2 may have 
had a beneficial effect on myoblast differentiation. The 
high level of myoblast fusion, coupled with the substan-
tial motor neuron presence in mixed ventral horn cul-
tures, demonstrates the suitability of medium 2 for the 
maintenance of MDC-motor neuron co-cultures. It 
should be stated that other factors relating to myoblast 
metabolism, growth, and/or survival may have been neg-
atively affected by addition of neuronal factors to the me-
dium, but were not measured in this study.
 MDC Differentiation in 3D Constructs Cultured with 
and without Motor Neurons  
 MDCs, maintained in medium 2, were found to dif-
ferentiate into uniaxially arranged myotubes ( fig.  1 b) 
that mimicked the physiological architecture of native 
skeletal muscle when cultured within the described 3D 
platform ( fig. 1 c). Fusion efficiencies of MDCs in 3D co-
culture and MDC-only controls were examined after 
18 DIV (14 DIV in co-culture), in order to determine 
whether or not co-culture with primary motor neurons 
had any effect on the ability of primary MDCs to differ-
entiate into multinuclear myotubes. Analysis showed 
that the fusion efficiencies of MDCs in mono- and co-
culture were 61.64% (±6.04) and 63.17% (±5.52), respec-
tively ( fig. 1 e). These values were not significantly differ-
ent from each other (p = 0.86), indicating that motor 
neuron presence had no negative effect on MDC ability 
to fuse in 3D co-culture. 
 Characterisation of Mixed Ventral Horn Cultures 
 Motor neurons from mixed ventral horn populations 
( fig. 1 d), maintained in medium 2, were found to consti-
tute 34.85% (±2.15) of all cells in culture following 7 DIV. 
This result is in line with data published previously re-
garding the size of the motor neuron fraction from un-
sorted ventral horn cells from our group [Kalmar and 
Greensmith, 2009] as well others [Bloch-Gallego et al., 
1991], indicating the suitability of the described protocol 
and medium composition for obtaining and culturing 
primary motor neurons in vitro.
 Motor Neuron Survival, Neurite Outgrowth, and NMJ 
Formation in 3D Co-Culture 
 Motor neuron survival following 14 days in 3D co-cul-
ture with primary MDCs was examined by immunostain-
ing for the neuronal marker MAP-2. The inherent hetero-
geneity of the primary cells employed in this co-culture 
system made distinguishing ventral horn-derived non-
neuronal nuclei from non-myogenic nuclei present in 
MDC cultures problematic. However, MAP-2 immuno-
staining indicated that a substantial number of neurons 
survived on the construct surfaces to the end of the des-
ignated culture period. No MAP-2-positive staining was 
observed on MDC-only control cultures, indicating that 
the MAP-2 staining observed in the co-cultures was not 
due to non-specific binding or background fluorescence.
 Confocal analysis of 3D tissue sections revealed that 
MAP-2-positive neurites had infiltrated into the body of 
the muscle constructs ( fig. 2 a, b), highlighting the ability 
of cultured motor neurons to promote growth cone exten-
sion through the collagen matrix. All neuritic extensions 
were detected within the first 100 μm of the 3D tissue 
across all cultures examined (n = 3), suggesting either that 
the axons were unable to penetrate deeper into the con-
struct or that cues from the myotubes at the surface pro-
moted neurite localisation in the periphery of the scaffold 
matrix. Neurites were typically seen running parallel, and 
in close proximity to, the underlying myotubes ( fig. 2 a; ar-
rows) but were also observed wrapping themselves around 
these multinuclear desmin-positive cells ( fig. 2 b; arrow).
 Co-localisation of AChRs stained with α-bungarotoxin 
and the pre-synaptic marker synaptic vesicle protein 2 
(SV-2) suggests the close association of pre- and post-
synaptic terminals in this model ( fig. 2 c, d). These struc-
tures mirrored those observed at functional NMJs in vivo 
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and provide evidence for the formation of putative NMJ-
like structures in these 3D collagen-based co-culture con-
structs. Strands of SV-2-positive staining were also con-
sistently observed running in close proximity to underly-
ing myotubes, indicating the path of developing neurites 
through the collagen construct. Incidences of pre- and 
post-synaptic marker co-localisation occurred at a fre-
quency of 4.24/mm 2 (±2.33) in the examined co-cultures 
(n = 4). In MDC-only control cultures, no positive SV-2 
staining was present, and so no co-localisation with AChR 
clusters was observed.
 Gene Expression Analysis in 3D Constructs Cultured 
with and without Motor Neurons 
 Quantitative RT-PCR results indicated the expression 
of multiple markers of skeletal muscle maturation present 
in both co-cultures and MDC-only constructs. Messen-
ger RNA transcripts for both developmental myosin 
heavy chain (MYH; MYH3 and MYH8) and adult 
(MYH1) isoforms were detected in all cultures examined 
(n = 3), along with transcripts for troponin T1, indicating 
a transcriptional drive towards the generation of the 
functional contractile machinery within the cultured 
myotubes. In these experiments, the addition of motor 
neurons was associated with a significant up-regulation 
of MYH3 (p < 0.01) and MYH8 (p < 0.03) mRNA expres-
sion compared with MDC-only controls. An increase of 
similar magnitude in MYH1 expression was also ob-
served, although this did not reach significance (p = 0.09). 
A significant 3-fold up-regulation (p < 0.05) in troponin 
T1 expression was also observed in co-culture constructs 
compared with MDC-only controls. The up-regulated 
MYH and troponin data indicate that the neuronal pres-
ence had a positive effect on the maturation of contractile 
machinery expression in the underlying myotubes in 
these cultures.
 AChRε subunit expression was significantly up-regu-
lated in co-culture constructs compared with MDC-only 
controls (p < 0.05), indicating a maturation of the AChR 
assemblies present in the membranes of myotubes co-
cultured with motor neurons. These data support previ-
ously discussed immunochemical analysis and provide 
further evidence for the formation of putative synaptic 
contact within these co-culture constructs ( fig. 3 ).
 Macroscopic Gel Contraction in 3D Constructs 
Cultured with and without Motor Neurons 
 Due to the high degree of matrix compaction in these 
constructs at end-point, single contractions of the cul-
tured myotubes could not be detected. In order to char-
acterise any macroscopic differences in levels of matrix 
compaction between co-cultures and MDC-only con-
trols, images were taken every 7 days during a 3-week 
culture period and analysed using ImageJ software. The 
surface area of the construct was used as a measure of ma-
trix remodelling, where a decrease in area correlated with 
an increase in matrix compaction. Although no differ-
ence was observed between co-cultures and MDC-only 
controls following 7 DIV ,  a divergence between the two 
cultures began to emerge by 14 DIV, where the average 
construct area in co-culture became smaller than that in 
MDC-only cultures. At 14 DIV, the construct surface area 
a
b
c
d
 Fig. 2. Neurite development and synaptic contact within 3D colla-
gen-based co-culture constructs. Longitudinal slices (30 μm) were 
taken from 3D constructs for immunostaining and imaging. 
 a ,  b Sections were stained for desmin (green) and MAP-2 (red). 
Scale bars = 20 μm.  c ,  d Sections were stained for SV-2 (green) and 
AChRs (red). Scale bars = 10 μm. a Neurites were typically seen 
tracking along parallel, and in close proximity to, underlying myo-
tubes (white arrows).  b Occasionally, neurites were also found 
wrapped around cultured myotubes (purple arrow).  c Pre- and 
post-synaptic co-localisation (blue arrow) was observed at a fre-
quency of 4.24/mm 2 .  d SV-2 tracks followed underlying myotube 
orientations (yellow arrows) indicating the path of neurite devel-
opment and axonal transport of synaptic proteins from the cell 
bodies toward the developing growth cone. 
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in 3D co-cultures was 222.35 mm 2 (±25.33) versus 307.54 
mm 2 (±42.24) in MDC-only controls. However, this dif-
ference was not significant (p = 0.159). By 21 DIV, how-
ever, the difference in average construct surface area was 
significant (p = 0.03), with co-culture constructs measur-
ing 162.00 mm 2 (±10.74; n = 5), while MDC-only controls 
measured 273.08 mm 2 (±34.44; n = 5) ( fig. 4 c). 
 Comparison of co-culture constructs with MDC-only 
controls showed increased thickening of the collagen ma-
trix along the outside edges of the collagen gel ( fig. 4 a, b). 
It is possible that this thickening was a result of increased 
collagen fibril density due to greater matrix contraction 
by MDCs. However, it may also have been due to cells 
within the mixed ventral horn population remodelling 
the collagen fibrils close to the construct surface and 
drawing them together. In order to investigate levels of 
matrix surface compaction by ventral horn cells in co-
culture, frozen cross sections were cut from both co- 
culture and MDC-only controls and immunostained 
for MAP-2 and desmin ( fig. 4 d, e). Analysis showed that 
MDC-only cultures displayed elongated cross-sectional 
structures with widths far greater than their heights, while 
MDC-motor neuron co-cultures, by comparison, pos-
sessed a cross section far closer to circular. While the cap-
tured images provide some evidence for surface compac-
tion of the collagen gels by mixed ventral horn cells, the 
rounded morphology of the co-culture cross sections, 
compared with the elongated shape of the MDC-only 
controls, also suggests an increased level of contraction 
from within the construct. This result was consistent 
across all cultures examined (n = 3) and implies that the 
increased matrix compaction observed in 3D co-culture 
was due to the action of non-neuronal cells within the 
mixed ventral horn population and the increase in activ-
ity of cultured MDCs. However, the precise mechanism 
behind this increased compaction could not be deter-
mined from the available data.
 Discussion
Relevance, Applications, and Future Perspectives for 
Neuromuscular Engineering 
 A 3D in vitro model of skeletal muscle capable of pro-
moting the formation of robust and functionally mature 
NMJs between co-cultured myotubes and motor neurons 
would be of considerable benefit to the continued study 
of neuromuscular physiology and pathology. Work with 
organotypic slices and neurospheres has demonstrated 
the possibility for promoting synaptic development be-
tween motor neurons and muscle in 3D culture. How-
ever, the use of these neuronal sources carries a degree of 
ambiguity with regard to which cells are interacting with 
which. The ability of dissociated neurons to survive and 
interact with 3D skeletal muscle models is beneficial, 
since it represents the development of a more fully de-
fined in vitro  platform of neuromuscular tissues. 
 Discussion of the Presented Data 
 In the presented original work, motor neurons were 
found to make up approximately 35% of the cells within 
the isolated primary ventral horn population, which is 
similar to numbers reported previously for such cultures 
[Bloch-Gallego et al., 1991; Kalmar and Greensmith, 
2009]. Culture of MDCs in a medium modified from one 
normally used for the culture of mixed ventral horn cells 
promoted MDC differentiation and myotube formation, 
indicating the suitability of this solution for maintaining 
MDC-motor neuron co-cultures.
 Our previous work regarding the development of a 3D 
collagen-based muscle model has provided evidence for 
high levels of myoblast alignment and differentiation in 
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 Fig. 3. Gene expression changes in motor neuron-muscle co-cul-
tures. Fold change in mRNA expression levels for genes encoding 
markers of myotube maturation and post-synaptic membrane de-
velopment, measured using quantitative RT-PCR. Expression lev-
els of MYH1 (adult fast isoform), MYH3 (embryonic isoform), 
and MYH8 (neonatal isoform), as well as troponin T1 and AChRε 
were quantified and expressed relative to levels recorded for 3D 
constructs without motor neurons at equivalent time points. In all 
cases, C T values were normalised to an internal housekeeping gene 
(RPIIB) before subsequent analysis. For all genes examined, with 
the exception of MYH1, values were found to be significantly 
greater than those recorded for MDC-only controls ( *  p < 0.05). 
n = 3. Error bars = SEM.  
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these constructs [Smith et al., 2012], producing ordered, 
parallel arrays of myotubes. MDCs were used instead of 
purified muscle stem cells in these cultures as fibroblasts 
are essential for effective collagen remodelling. In vivo, 
fibroblasts are responsible for producing, organizing, 
and remodelling the extracellular matrix and, particu-
larly, collagen fibrils [Gillies and Lieber, 2011]. In order 
to ensure effective matrix restructuring, a mixed popula-
tion of myoblasts and fibroblasts was, therefore, consid-
ered beneficial. This hypothesis is supported by previous 
work in our group that has shown that purified myo-
blasts exert weaker remodelling forces and strain devel-
opment in 3D constructs than mixed myogenic and non-
myogenic populations [Brady et al., 2008]. The develop-
ment of an aligned and anisotropic cellular architecture 
mimics that seen in the native skeletal muscle tissue 
( fig. 1 b, c), and highlights the suitability of this model for 
further development towards the production of a more 
biomimetic skeletal muscle culture system. Furthermore, 
the ability to maintain densely seeded MDC constructs 
over many weeks in vitro makes this system well suited 
to the production of stable co-cultures for long-term 
analysis. 
 Immunostaining of muscle-motor neuron 3D con-
structs demonstrated the ability for these co-cultures to 
promote regular apposition of pre- and post-synaptic ter-
minals, suggesting the formation of preliminary synaptic 
contacts between both cell types. As in previous in vitro 
studies [Bach et al., 2003; Miles et al., 2004; Larkin et al., 
2006b; Dhawan et al., 2007; Guo et al., 2011; Smith et al., 
2013], co-localisation of pre- and post-synaptic markers 
in these co-cultures lacked the clear definition of NMJs in 
vivo [Akaaboune et al., 1999; Sanes and Lichtman, 2001]. 
This is likely due to the immature nature of the cells uti-
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 Fig. 4. The effect of motor neuron presence on matrix compaction. 
 a ,  b Macroscopic images of collagen constructs seeded with 5 × 10 6 
MDCs/ml following 21 DIV. Scale bars = 25 mm.  a MDC-only 
control.  b Motor neuron-myotube co-culture.  c Graph detailing 
the measured reduction in surface area of collagen constructs seed-
ed with 5 × 10 6 MDCs/ml either in co-culture with motor neurons 
(solid line) or in monoculture (dashed line). n = 5. Error bars = 
SEM.  *  p = 0.03.  d ,  e 30-μm-thick cross sections were taken from 
3D collagen-based constructs seeded with 5 × 10 6 MDCs/ml and 
stained for desmin (green) and MAP-2 (red). Note the difference 
in shape between the rounded construct co-cultured with 1 × 10 6 
motor neurons ( d ) and the elongated MDC-only control ( e ). N.B. 
The image in  e represents half the total width of the construct since 
the entire gel was too large to section reliably. Similar results were 
obtained across all cultures examined (n = 3).  d ,  e The widths of 
the constructs are indicated by red scale bars. These dimensions 
correspond to those indicated in the macroscale images presented 
in  a and  b . Note that the width in muscle-only constructs is far 
greater than the orthogonal height, whereas the neuron-muscle 
co-cultures possess a more rounded morphology. Scale bars = 
100 μm. 
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lised for this study, and steps to promote a greater degree 
of cellular maturation, such as neuronal excitation, may 
be able to promote the generation of developmentally ad-
vanced and robust synaptic contacts between these cell 
types. Previous work has shown that culture systems such 
as those described here can support electrical and me-
chanical stimulation [van der Schaft et al., 2013; Player et 
al., 2014], meaning that the development and incorpora-
tion of muscle maturation stimuli into this model are a 
credible possibility for future studies. AChRε gene ex-
pression has been shown previously to be present spe-
cifically in the subsynaptic nuclei of innervated muscle 
fibres [Brenner et al., 1990; Gundersen et al., 1993]. The 
up-regulation of mRNA transcripts for this gene in these 
3D co-cultures, therefore, suggests a level of maturation 
within the AChR subunit composition of the cultured 
myotubes when maintained in close association with sup-
porting motor neurons, providing further evidence for 
synaptic development and the specialisation of the post-
synaptic membrane.
 Gene expression analysis from these collagen-based 
co-cultures highlighted a significant increase in MYH3, 
MYH8, and troponin T1 mRNA transcripts when com-
pared to MDC-only controls. These data suggest a level 
of maturation in myotubes co-cultured with motor neu-
rons in 3D through the up-regulation of transcripts for 
contractile apparatus proteins. However, the modest in-
crease in expression of the adult MYH isoform (MYH1) 
points toward a relatively immature overall transcrip-
tion profile, with no evidence of the isoform switching 
that would accompany muscle maturation during nor-
mal embryonic and postnatal development in vivo. The 
somewhat immature nature of the cultured myotubes is 
further evidenced by the lack of striations observed in 
the immunostained cells compared with in vivo  coun-
terparts ( fig.  1 b, c). Despite this immaturity, the high 
level of construct stability observed in this system pro-
vides the possibility to extend culture periods over far 
longer time courses than is possible in conventional 2D 
skeletal muscle culture. In this manner, analysis of 
whether more developmentally mature transcription 
profiles can be achieved in long-term culture is a viable 
option for future studies. Previous studies assessing 
skeletal muscle gene expression provided evidence for a 
greater degree of adult MYH gene expression in con-
structs maintained in co-culture with neural tissue [Lar-
kin et al., 2006b]. As stated previously, this study utilised 
organotypic spinal cord explants as their motor neuron 
source. The increased muscle maturation reported in 
the study published by Larkin et al. [2006] may, there-
fore, be attributable to the presence of supporting cell 
types and associated tissue structures in the slice prepa-
ration rather than the motor neuron presence specifi-
cally. Since these structures and/or cell types were absent 
or present in different ratios in our preparations, the re-
sulting maturation signal may have been weakened. The 
comparative data indicate that more rigid conformity to 
tissue level architectures and cell ratios may be required 
when using dissociated single neurons in order to obtain 
optimal maturation signals for promoting muscle devel-
opment.
 The use of collagen matrices in this study yielded ro-
bust and stable constructs capable of persisting in cul-
ture for over 3 weeks. However, extensive compaction 
of the matrix by fibroblasts led to the formation of rigid 
structures, which made effective assessment of contrac-
tile function difficult. This is not surprising since this 
model was originally optimised to produce long-term 
stable muscle constructs for investigating alterations in 
strain and loading in vitro  [Cheema et al., 2005]. Given 
the primary purpose of this study was to investigate neu-
romuscular contact in 3D systems and the maturation 
effect of the motor neuron presence on cultured skeletal 
muscle myotubes, an inability to measure contraction 
was not considered a cause for concern. The contractile 
ability of cells developed within the described culture 
conditions was verified by visual inspection of cells in 
conventional 2D culture. Myotubes maintained in me-
dium 2 exhibited spontaneous contractile activity as ev-
idenced by twitching cells (data not shown). However, 
as already discussed, the lack of striations in the 3D cul-
tured myotubes likely indicates that the generated force 
from such contractions was relatively weak. The capac-
ity for these collagen constructs to be subjected to me-
chanical strain regimens [Auluck et al., 2005; Cheema et 
al., 2005; Player et al., 2014] represents an exciting pos-
sibility for the future use of this system and a means to 
promote myotube maturation to the point where con-
tractile behaviour can be more readily investigated. Fur-
thermore, analysis of NMJ development under different 
loading and unloading conditions will yield valuable 
data on the importance of mechanical cues on neuromo-
tor synaptogenesis. For analysis of contractile function, 
alternative, more flexible matrices should be considered. 
Studies have shown that supplementation of basal ma-
trices with Matrigel improves the measured contractile 
function in engineered skeletal muscle constructs, sug-
gesting that manipulating the elastic modulus of engi-
neered matrices by mixing biopolymers enables greater 
flexibility and, therefore, a greater ability for cultured 
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cells to deform the scaffold [Hinds et al., 2011]. As proof 
of this, our group’s recent study utilising similar nerve-
muscle co-culture conditions within a fibrin-based ma-
trix demonstrated the ability for such cells to generate 
measurable force. Moreover, this study highlighted that 
co-culture with motor neurons led to a degree of neuro-
nal control over myotube activation, functional matura-
tion, and cytoskeletal organisation [Martin et al., 2015]. 
While valuable for functional studies, these fibrin con-
structs were less stable over long-term culture periods 
and so were ill suited to more extended studies of NMJ 
maturation in vitro. Our fibrin study and the collagen-
based work presented here highlight the importance of 
selecting appropriate matrix modalities for tissue engi-
neering experiments based on the specific goals of the 
study.
 Significant differences were observed in the level of 
matrix remodelling in the MDC-motor neuron co-cul-
tures compared with MDC-only controls. After 3 weeks 
in vitro, co-culture construct surface areas were signifi-
cantly smaller than those of MDC-only controls, sug-
gesting the level of matrix contraction in co-culture was 
significantly greater. As described previously, the re-
modelling observed in these constructs as they develop is 
thought to correlate with the level of cellular matrix re-
modelling occurring in culture; the greater the activity of 
the fibroblasts in culture, the larger the level of bowing 
observed in the construct. However, myotubes in culture 
also spontaneously contract, and culture force monitor 
recordings from mixed myoblast and fibroblast 3D con-
structs have demonstrated a significantly greater level of 
overall strain compared with purified fibroblast or myo-
blast cultures [Brady et al., 2008]. It seems likely that 
myotube activity would also contribute to the levels of 
matrix contraction occurring in these 3D constructs, 
which in turn may be mediated by the addition of a neu-
ronal input, potentially explaining the increased matrix 
remodelling. Although contraction by non-neuronal 
cells within the mixed ventral horn population also like-
ly contributed to the observed result, the rounded mor-
phology of the co-culture cross sections, compared with 
the elongated MDC-only control morphology, suggests 
greater levels of contraction from MDCs within the col-
lagen matrix. 
 Applications of Tissue-Engineered Innervated Skeletal 
Muscle Models 
 This work constitutes the first time that dissociated 
motor neurons have been evaluated in collagen-based 3D 
co-culture with skeletal muscle cells. The collected data, 
therefore, provide important proof of principle for the 
use of such cells in 3D muscle culture and in the develop-
ment of more defined, complex models of skeletal muscle 
tissue. Isolated motor neurons are able to survive in this 
collagen-based 3D skeletal muscle model and are capable 
of promoting the formation of preliminary neuromuscu-
lar contacts whilst maintaining the ordered cellular archi-
tecture and maturity of the cultured myotubes. The up-
regulation of transcripts for contractile machinery pro-
teins and markers of post-synaptic terminal specialisation 
suggest that motor neurons promote the maturation of 
the underlying muscle in these cultures, as is known to 
occur in vivo. 
 The establishment of a 3D platform for dissociated 
motor neuron-muscle co-cultures has obvious potential 
benefit for the development of disease models incorpo-
rating iPSCs. The increasing prevalence of human iPSC 
technologies since their inception [Takahashi et al., 2007; 
Yu et al., 2007] now means that the establishment of dis-
eased cell types carrying patient-specific mutations for 
more accurate recapitulation of a given condition’s patho-
physiology is a plausible eventuality [Thomson et al., 
2012]. This holds exciting promise, particularly for the 
study of conditions for which no good animal model ex-
ists. For example, the standard therapeutic model for ALS 
is the SOD1G93A mouse model which carries 23 copies 
of the SOD1G93A transgene [van der Worp et al., 2010]. 
SOD1 mutations only account for a very small fraction of 
total ALS cases ( ∼ 3%), so such studies are only directly 
relevant to this subset of patients [Scott et al., 2008; van 
der Worp et al., 2010]. Furthermore, it has been high-
lighted that the phenotype of these mice is so exaggerated 
by the 23 copies of the transgene present that the only 
pharmacological intervention capable of attenuating the 
effect is direct inhibition of SOD1 [Scott et al., 2008; van 
der Worp et al., 2010]. Evidence has been put forward to 
suggest that these SOD1 mutant mice have a greater sus-
ceptibility to infections and other non-ALS-related con-
ditions, and it has been implied that it is this supplemen-
tary illness, rather than ALS, that is alleviated by certain 
experimental treatments. Consistent with this hy po-
thesis, some broad-spectrum antibiotics and general 
anti-inflammatory agents have been shown to be effica-
cious in alleviating the pathophysiological phenotype in 
SOD1G93A mouse models [Scott et al., 2008]. In cases 
such as this, the possibility of generating cells carrying 
patient-specific mutations may enable more accurate re-
capitulation of the disease phenotype, leading to more in-
formative mechanistic studies and predictive novel thera-
peutic screening applications. Effective models of com-
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plex conditions such as ALS have yet to be achieved, but 
diseased NMJ models have been established for myoton-
ic dystrophy [Marteyn et al., 2011] and spinal muscular 
atrophy [Yoshida et al., 2015], demonstrating that such 
model systems are possible.
 Compound efficacy/toxicity screening is a second av-
enue of research for which neuromuscular models could 
be utilised effectively. Current development protocols 
can take over a decade and cost over USD 1 billion [Di-
Masi and Grabowski, 2007]. A substantial reason for this 
cost is the high rate of attrition of compounds at late de-
velopment stages, which is in turn due to the inadequacy 
of preclinical models in terms of predicting drug effects 
in humans [Esch et al., 2014]. As already discussed, ani-
mal models often represent poor surrogates for human 
systems, and conventional cell culture techniques do little 
to recreate the structure, maturation, and functional pro-
files of the native tissue. The generation of biomimetic 
muscle models with functional innervation could, there-
fore, prove invaluable to the screening of novel paralytics, 
muscle relaxants, and treatments for peripheral neuro-
pathic conditions [Beebe et al., 2005]. The generation of 
multiwell high-throughput contractility assays for skele-
tal muscle [Vandenburgh et al., 2008, 2010] serves to 
highlight further the possibility of generating informative 
and highly predictive screening systems with which to ad-
vance therapeutic developments to better suit the needs 
of patients. 
 Innervated 3D skeletal muscle models also have the 
potential for utility in experimental physiology, particu-
larly as a means of investigating the basic biology under-
pinning NMJ formation. Indeed, in vitro culture models, 
such as those described here, are amenable to mechanical 
strain [Player et al., 2014] and electrical stimulation 
[Khodabukus and Baar, 2012], which are key signals like-
ly governing the development of the neuromuscular sys-
tem in utero, and as such could be used to understand 
how these signals alter neuromuscular maturation. More-
over, both mechanical and electrical signals regulate mus-
cle adaptation and phenotype in adults (i.e. exercise/dis-
use) and as such 3D skeletal muscle constructs with a neu-
ral input, which accurately replicate the in vivo niche, 
could be used to manipulate and further understand the 
basis of muscle plasticity. Additionally, the ability to com-
bine mechanical and electrical stimuli with exogenous 
growth factors or putative nutraceuticals in an integrated 
neuromuscular model would allow for the highly con-
trolled investigation of regulators of skeletal muscle plas-
ticity.
 Future Perspectives 
 Before tissue-engineered models of innervated skeletal 
muscle can become viable for widespread adoption, there 
is a clear need to address issues with maturation. Ad-
vanced states of NMJ maturation have been shown in 
conventional 2D hybrid cultures [Chipman et al., 2014]; 
however, no such structures have yet been presented in 
3D constructs. Methods for maturing constructs in situ 
must be investigated in order to advance the development 
of current models toward more biomimetic tissues. Fur-
thermore, little investigation of developing the excita-
tion-contraction coupling machinery has been undertak-
en in co-cultured cells to date. Although numerous stud-
ies highlight the development of pre- and post-synaptic 
terminals in vitro ,  the formation of robust t-tubules ex-
pressing ryanodine receptors linked to the sarcoplasmic 
reticulum is essential for complete development of inner-
vated skeletal muscle models. The 3D models presented 
and discussed here represent ideal platforms in which to 
investigate how NMJ formation advances the develop-
ment of the physiologically correct excitation-contrac-
tion coupling machinery and, in doing so, drives the mat-
uration of cultured skeletal muscle towards a more bio-
logically relevant phenotype. 
 It has been shown that repetitive electrical stimulation 
of motor neuron-myotube cultures for 30–60 min sig-
nificantly up-regulates synapsin expression and AChR 
clustering, suggesting such stimuli may be employed to 
improve NMJ formation in culture [Fukazawa et al., 
2013]. This result is logical, given the activity dependence 
of NMJ structure and development in vivo [Ataman et al., 
2008]. Other studies have demonstrated that mechanical 
stimuli can be used to advance the maturation of skeletal 
muscle constructs [Player et al., 2014], opening up the 
possibility for investigating concerted electromechanical 
conditioning as a means to push innervated skeletal mus-
cle constructs toward a more adult phenotype in vitro.
 Other considerations for advancing neuromuscular in-
teractions in vitro are the inclusion of terminal Schwann 
cells and ‘kranocytes’ (NMJ-capping cells) to better mimic 
the native structure of synapses [Koirala et al., 2003; Court 
et al., 2008; Darabid et al., 2014]. Although establishment 
of triple cell type cultures is daunting, it is possible that in-
clusion of these cells will provide valuable maturation sig-
nals for developing NMJs. Linked to the inclusion of sup-
porting glia in NMJ development is the discovery that, in 
drosophila, the glia-released Maverick protein activates 
the transforming growth factor-β (TGF-β) receptor on de-
veloping muscle membranes, which in turn leads to the 
activation of neuronal receptors via a retrograde signalling 
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pathway to help modulate synaptogenesis [Fuentes-Medel 
et al., 2012]. Similarly, in  Xenopus  studies, TGF-β has been 
shown to promote agrin up-regulation and subsequent in-
creased AChR clustering [Feng and Ko, 2008]. Given these 
findings, it may be possible to attain the positive effects of 
Schwann cell presence in culture without having to incor-
porate a third cell type, simply through modification of 
current culture media to include the necessary glial-de-
rived factors (such as TGF-β).
 In addition to other NMJ-related cell types, another 
direction for future research is to investigate the potential 
integration of innervated muscle models with representa-
tions of bone and tendon in order to create more compre-
hensive analogues of musculoskeletal tissues. As men-
tioned previously, in vitro  models of the myotendinous 
junction have been published [Larkin et al., 2006a; Kostro-
minova et al., 2009], and the techniques underpinning the 
production of tissue-engineered cartilage and bone are 
similarly well advanced [Chen et al., 2015; Huang et al., 
2015; Wu et al., 2015]. Integration of these systems, lead-
ing to the generation of a muscle-tendon-bone model, 
would be extremely beneficial for future studies into 
 musculoskeletal development, response to physiological 
strain, and breakdown in ageing and disease. 
 A final consideration is the generation of human iPSC 
myoblasts for these systems. Almost all models discussed 
in this paper make use of primary rodent tissue or im-
mortalised cell lines to provide the muscle source. This is 
likely due to the ease with which such cells can be main-
tained in culture and the comparative difficulty in main-
taining motor neurons. However, in order to recapitulate 
the human NMJ effectively, especially in case of model-
ling genetic disorders, techniques for generating human 
muscle from stem cells must catch up with efforts to gen-
erate functional motor neurons. Although some work 
with human co-cultures has been performed [Guo et al., 
2011], the cells used were not iPSCs. The differentiation 
of myoblasts from iPSCs is not as well established as mo-
tor neuron differentiation, but significant progress to-
ward the successful production of human myotubes 
from these cells has been made [Watanabe et al., 2011; 
Trokovic et al., 2013; Demestre et al., 2015]. Addition-
ally, improvement in motor neuron differentiation to en-
able directed production of specific subtypes is also un-
derway [Peljto et al., 2010; Patani et al., 2011]. These ad-
vances will be of critical importance to the continued 
development of more biologically accurate neuromuscu-
lar tissue-engineering strategies and likely be instrumen-
tal advancing the utility of these models in the near fu-
ture.
 Conclusions 
 NMJ engineering holds exciting promise for the devel-
opment of predictive platforms for disease modelling, 
drug screening, and other applications. As technologies 
for manipulating human ESC and iPSC types become 
more prevalent, the possibilities for generating accurate 
human models become tantalising. As the data presented 
here and by others attest, the formation of putative syn-
aptic contacts is possible using a variety of cell types and 
a number of different platforms. Efforts must now be fo-
cused on promoting the maturation of motor neuron-
myotube co-cultures in order to generate adult-like tissue 
structures for effective modelling studies. 
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